ICMR-NIE Launches Data Analytics Platform to Strengthen India’s Outbreak Response

IMT News Desk
IMT News Desk
· 3 min read
ICMR-NIE launches ADARV data analytics platform for outbreak response in India, enabling rapid analysis of field data within hours like weather forecasting

The Indian Council of Medical Research’s National Institute of Epidemiology (ICMR-NIE), Chennai, has launched a first-of-its-kind data analytics platform called ADARV (Advanced Data Analytics for Public Health Action and Research Venture), designed to strengthen epidemic intelligence and enhance outbreak response through data-driven analytics.

In collaboration with the Centre of Data for Public Good (CDPG) and the Isaac Centre for Public Health (ICPH) at the Indian Institute of Science (IISc), Bengaluru, ICMR-NIE announced the launch of ADARV at an online event on Friday, June 5, 2026, with researchers, field epidemiologists, technology experts and policymakers from across the country attending the event.

ADARV is designed to make epidemic intelligence “as fast, reliable and actionable as weather forecasting”, according to its developers, enabling users to rapidly analyse outbreak data and generate insights without relying on external software or specialised statistical expertise.

Beyond analytics, ADARV also serves as a public health data warehouse for India, allowing researchers and institutions to upload their datasets and share them openly with the broader research community.

“This open, structured repository aims to shift the culture around health data, from silos to sharing and build a growing common of outbreak intelligence that the entire research ecosystem can learn from,” the platform’s developers said, with officials stating the initiative aims to promote a culture of data sharing in public health by creating an open and structured repository of outbreak-related information.

The platform is expected to support collaborative research and strengthen evidence-based decision-making during public health emergencies, according to officials.

ADARV bridges the gap between data collection and public health action, fundamentally strengthening how researchers investigate outbreaks and make field decisions, with field data collected in the morning during a hepatitis outbreak in Haryana being fully analysed within an hour.

“It allows field teams to upload outbreak data and generate time-place-person analyses within hours rather than weeks. The reports can also be shared with stakeholders,” said a team member explaining the platform’s capabilities.

Dr. Sharan Murali, Scientist at ICMR-NIE and lead epidemiologist of the ADARV team, said that the platform is currently being used to support outbreak investigations in Kerala.

“ADARV envisions transforming field data into actionable intelligence, enabling researchers, epidemiologists, and decision-makers to detect signals earlier, understand outbreaks better, and respond faster,” according to the platform’s vision statement.

The platform is a free-to-use service, and access is available upon request through adarv@nieicmr.org.in or at https://adarv.in.

Developed through a collaboration between health researchers and technology experts, ADARV combines epidemiological expertise with modern data infrastructure and analytics capabilities to support epidemic intelligence efforts.

The initiative brings together ICMR-NIE’s epidemiological expertise with IISc’s technological capabilities, representing a multisectoral approach to strengthening India’s public health preparedness and response systems.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk